<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>News and Trends on Pharma Industry Production &amp; Manufacturing</title>
	<atom:link href="https://www.worldpharmatoday.com/production-manufacturing/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Fri, 18 Sep 2026 22:51:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.1</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>News and Trends on Pharma Industry Production &amp; Manufacturing</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Onyx Scientific Boosts API Manufacturing Capacity in UK</title>
		<link>https://www.worldpharmatoday.com/press-releases/onyx-scientific-boosts-api-manufacturing-capacity-in-uk/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 18 Sep 2026 22:51:07 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/onyx-scientific-boosts-api-manufacturing-capacity-in-uk/</guid>

					<description><![CDATA[<p>Onyx Scientific, a global small molecule CDMO, is investing more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities and increase commercial active pharmaceutical ingredient (API) production at its Sunderland UK facility. The expansion will add four GMP suites, taking the total from six to ten, while increasing capacity for commercial API production and [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/onyx-scientific-boosts-api-manufacturing-capacity-in-uk/">Onyx Scientific Boosts API Manufacturing Capacity in UK</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Neuland Expands Peptide Manufacturing Capacity in India</title>
		<link>https://www.worldpharmatoday.com/press-releases/neuland-expands-peptide-manufacturing-capacity-in-india/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 18 Sep 2026 22:31:56 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/neuland-expands-peptide-manufacturing-capacity-in-india/</guid>

					<description><![CDATA[<p>Neuland Laboratories is accelerating its peptide manufacturing expansion, with the first of four planned modules now operational at its commercial peptide manufacturing site in Hyderabad. The company said the newly commissioned module is designed to meet growing customer demand and support programmes ranging from small-scale to multikilogram quantities for complete peptide APIs, including complex and [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/neuland-expands-peptide-manufacturing-capacity-in-india/">Neuland Expands Peptide Manufacturing Capacity in India</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Upstream Process Optimization for Biologics Production Efficiency</title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/upstream-process-optimization-for-biologics-production-efficiency/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 14 Sep 2026 07:50:38 +0000</pubDate>
				<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/upstream-process-optimization-for-biologics-production-efficiency/</guid>

					<description><![CDATA[<p>The efficiency of biologics production is fundamentally determined at the start of the development cycle during cell line selection. Chinese Hamster Ovary cells remain the industry standard due to their ability to perform human-like post-translational modifications, which are essential for the efficacy and safety of monoclonal antibodies. Achieving high productivity requires a strategic approach to [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/upstream-process-optimization-for-biologics-production-efficiency/">Upstream Process Optimization for Biologics Production Efficiency</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>mRNA Manufacturing Platforms for Advanced Therapy Scalability</title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/mrna-manufacturing-platforms-for-advanced-therapy-scalability/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 14 Sep 2026 07:39:15 +0000</pubDate>
				<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/mrna-manufacturing-platforms-for-advanced-therapy-scalability/</guid>

					<description><![CDATA[<p>The rapid development of messenger RNA technology has necessitated a shift in how the pharmaceutical sector approaches the production of advanced therapies. Unlike traditional biologics that rely on complex cell culture systems, mRNA manufacturing platforms utilize cell-free enzymatic synthesis, primarily through in vitro transcription. This process involves the use of a DNA template and RNA [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/mrna-manufacturing-platforms-for-advanced-therapy-scalability/">mRNA Manufacturing Platforms for Advanced Therapy Scalability</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Pharmaceutical Analytical Testing for Drug Product Quality</title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/pharmaceutical-analytical-testing-for-drug-product-quality/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 14 Sep 2026 07:25:27 +0000</pubDate>
				<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/pharmaceutical-analytical-testing-for-drug-product-quality/</guid>

					<description><![CDATA[<p>The maintenance of high standards in the pharmaceutical sector is intrinsically linked to the rigor of analytical procedures used throughout the drug development lifecycle. Effective pharmaceutical analytical testing provides the foundational data necessary to verify the identity, purity, and potency of both raw materials and final drug products. High-performance liquid chromatography remains the primary tool [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/pharmaceutical-analytical-testing-for-drug-product-quality/">Pharmaceutical Analytical Testing for Drug Product Quality</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Bioavailability Optimization Techniques for Small Molecule Drug Performance</title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/bioavailability-optimization-techniques-for-small-molecule-drug-performance/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 14 Sep 2026 07:01:33 +0000</pubDate>
				<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/bioavailability-optimization-techniques-for-small-molecule-drug-performance/</guid>

					<description><![CDATA[<p>The pharmaceutical sector continues to encounter significant hurdles in small molecule drug development, primarily due to the poor aqueous solubility of emerging chemical entities. As drug discovery pipelines shift toward more complex molecular structures, a high percentage of new chemical entities fall into Classes II and IV of the Biopharmaceutical Classification System. These compounds exhibit [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/bioavailability-optimization-techniques-for-small-molecule-drug-performance/">Bioavailability Optimization Techniques for Small Molecule Drug Performance</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>ABEC Opens New Biopharmaceutical Manufacturing Facility in Wilson, North Carolina</title>
		<link>https://www.worldpharmatoday.com/news/abec-opens-new-biopharmaceutical-manufacturing-facility-in-wilson-north-carolina/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 14:04:55 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/abec-opens-new-biopharmaceutical-manufacturing-facility-in-wilson-north-carolina/</guid>

					<description><![CDATA[<p>ABEC is set to open a new manufacturing facility in Wilson, North Carolina, further strengthening its network of biopharmaceutical process equipment and consumables production. A ribbon-cutting ceremony to mark the occasion is scheduled for 24 September, with company leadership, employees, partners, and community leaders expected to attend. A New Hub for Bioprocess Equipment and Consumables [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/news/abec-opens-new-biopharmaceutical-manufacturing-facility-in-wilson-north-carolina/">ABEC Opens New Biopharmaceutical Manufacturing Facility in Wilson, North Carolina</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Continuous Manufacturing Improving Small-Molecule Production Efficiency</title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/continuous-manufacturing-improving-small-molecule-production-efficiency/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 05 Sep 2026 08:24:21 +0000</pubDate>
				<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/continuous-manufacturing-improving-small-molecule-production-efficiency/</guid>

					<description><![CDATA[<p>The pharmaceutical industry is currently undergoing a significant shift from traditional batch processing toward integrated systems that prioritize speed and consistency. For decades, the production of active pharmaceutical ingredients has relied on segregated steps, where each stage of synthesis occurs in isolation. This legacy approach often results in long lead times, increased inventory costs, and [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/continuous-manufacturing-improving-small-molecule-production-efficiency/">Continuous Manufacturing Improving Small-Molecule Production Efficiency</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Technology Transfer Strategies Accelerating Multi-Site Pharmaceutical Scale-Up</title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/technology-transfer-strategies-accelerating-multi-site-pharmaceutical-scale-up/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 05 Sep 2026 08:20:11 +0000</pubDate>
				<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/technology-transfer-strategies-accelerating-multi-site-pharmaceutical-scale-up/</guid>

					<description><![CDATA[<p>The expansion of pharmaceutical manufacturing capabilities from a single development site to a network of global production facilities is a complex undertaking that requires meticulous planning and coordination. As the demand for new therapies increases, the ability to replicate a validated process across different geographic locations becomes a critical competitive advantage. Organizations are increasingly focusing [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/technology-transfer-strategies-accelerating-multi-site-pharmaceutical-scale-up/">Technology Transfer Strategies Accelerating Multi-Site Pharmaceutical Scale-Up</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Large Molecule Development Supporting Complex Biologic Drug Programs</title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/large-molecule-development-supporting-complex-biologic-drug-programs/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 31 Aug 2026 08:07:24 +0000</pubDate>
				<category><![CDATA[BioPharma]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/large-molecule-development-supporting-complex-biologic-drug-programs/</guid>

					<description><![CDATA[<p>The pharmaceutical industry is experiencing a profound expansion in the biologic sector, driven by the need for more targeted and effective therapies for chronic diseases. Unlike small molecules, biologics are produced in living systems, which introduces a high degree of complexity in both discovery and manufacturing. This complexity necessitates a rigorous approach to large molecule [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/large-molecule-development-supporting-complex-biologic-drug-programs/">Large Molecule Development Supporting Complex Biologic Drug Programs</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
